SIGILON THERAPEUTICS INC - COM (SGTX)

CUSIP: 82657L107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
9,265,183
Share change
+9,265,183
Total reported value
$443,802,751
Price per share
$48.03
Number of holders
44
Value change
+$443,802,751
Number of buys
44

Quarterly Holders Quick Answers

What is CUSIP 82657L107?
CUSIP 82657L107 identifies SGTX - SIGILON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIGILON THERAPEUTICS INC - COM (SGTX) as of Q4 2020

As of 31 Dec 2020, SIGILON THERAPEUTICS INC - COM (SGTX) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,265,183 shares. The largest 10 holders included CANADA PENSION PLAN INVESTMENT BOARD, BlackRock Inc., FMR LLC, HarbourVest Partners LLC, Avidity Partners Management LP, GILDER GAGNON HOWE & CO LLC, SPHERA FUNDS MANAGEMENT LTD., Monashee Investment Management LLC, STATE OF WISCONSIN INVESTMENT BOARD, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.